Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alimera Sciences
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Any patient treated with Iluvien under this protocol will be included in the study.
You may not be if
Patients/Guardians who are unable to understand and sign the Informed Consent will be excluded from the study.
Retrospective Enrollment Criteria
1. The site is allowed to enroll a patient who was treated with ILUVIEN no more than 36 months prior to bringing the patient in for their first study visit.
2. The eligible patient must meet the data requirements as specified in the protocol, i.e., baseline data collected within 7 days prior to treatment with ILUVIEN and additional data subsequently collected approximately every 6 months thereafter until enrolment into the study.
3. The eligible patient must be enrolled at least one year prior to the planned end of the study.
